Skip to main content
. 2021 Feb 11;57(2):2002718. doi: 10.1183/13993003.02718-2020

TABLE 3.

Treatments received by patients in the cohort at any time during the course of the study period

Patients with ≥1 treatment 163
Treatment received
 Azithromycin 6 (3.7)
 N-Acetylcysteine 12 (7.4)
 Oxygen therapy 58 (35.6)
 Glucocorticoids 145 (89.0)
 Immunosuppressive agents
  Mycophenolate mofetil 63 (38.7)
  Cyclophosphamide 39 (23.9)
  Rituximab 29 (17.8)
  Azathioprine 24 (14.7)
  Methotrexate 21 (12.9)

Data are presented as n or n (%).